Recombinant oncolytic poliovirus combined with checkpoint blockade for breast cancer therapy.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Clinical Oncology

• Publication date

  2018-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1200/JCO.2018.36.15_SUPPL.E12641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade

  2021cites this paper
• Prognostic Model Construction and Immune Microenvironment Analysis of Breast Cancer Based on Ferroptosis-Related lncRNAs

  2021cites this paper
• Combination therapy with oncolytic viruses and immune checkpoint inhibitors

  2020influential citation
• Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials

  2020cites this paper
• Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading

  2019cites this paper